Results 81 to 90 of about 3,929 (111)

Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study). [PDF]

Front Med (Lausanne)
Campos C, Fito-Manteca MC, Valero-Martínez C, García-Carazo S, Almodóvar R, Díaz-Cerezo S, Moyano S, Cobo A, Aguirregabiria I, Pérez-Rambla C, Pérez-Sádaba FJ, Navarro-Compán V.   +11 more
europepmc   +1 more source

Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. [PDF]

Rheumatol Ther
Mease P, Ye X, Saffore CD, Parikh B, Ciecinski S, Blachley T, Eliot M, Middaugh N, Ogdie A.   +8 more
europepmc   +1 more source

Patients' Perspectives Regarding Ankylosing Spondylitis Treatment Administration Features: Evidence from Qualitative Interviews and a Multinational Quantitative Preference Survey. [PDF]

Rheumatol Ther
Deodhar A, Maculaitis MC, Kopenhafer L, Beusterien K, Ling YL, Hauber B, Cappelleri JC, Yndestad A, Phillips LR, Zayed M.   +9 more
europepmc   +1 more source

Efficacy & safety of adalimumab biosimilar in axial spondyloarthritis: A retrospective study from a tertiary care centre in South India. [PDF]

Indian J Med Res
Gopalan A, Gavali M, Yerram K.
europepmc   +1 more source

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. [PDF]

RMD Open
Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, D'Agostino MA, Gaffney K, Kay J, de la Loge C, Massow U, Taieb V, Vaux T, Deodhar A.   +13 more
europepmc   +1 more source

Assessment of the Concomitance of Fibromyalgia in Patients with Axial Spondyloarthritis and Rheumatoid Arthritis. [PDF]

Arch Rheumatol
Caglayan M, Oktayoglu P, Celik Y, Gunduz İ, Sula ZI, Ciftci M, Yıldız İ.   +6 more
europepmc   +1 more source

Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. [PDF]

Arthritis Res Ther
Ramiro S, Proft F, Sengupta R, van Tubergen A, Moltó A, Gensler LS, Kishimoto M, Taieb V, Kavanagh S, Evans S, Navarro-Compán V.   +10 more
europepmc   +1 more source

Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study. [PDF]

Reumatologia
Koç E, Okyar B, Bakırcı S, Badak SÖ, Demir AN, Uçar İ, Sargın G, Yüce S, Ersözlü ED.   +8 more
europepmc   +1 more source

Axial spondyloarthritis treatment patterns, clinical characteristics and patient-reported outcome collection in US rheumatology practices. [PDF]

Rheumatol Adv Pract
Concoff A, Taiji R, Grinnell-Merrick L, Rodrigues J, McDermott C, Haber R, Ionescu-Ittu R, Faucher A, Vekeman F, Nguyen T.   +9 more
europepmc   +1 more source

Relationship between ultrasound damage score of peripheral entheses and spinal bone formation in long-standing radiographic axial spondyloarthritis. [PDF]

RMD Open
Deminger A, Geijer M, Hallström M, Jacobsson LTH, Forsblad-d'Elia H.   +4 more
europepmc   +1 more source